Search research articles
Contact Us
Filters
Showing results (571-580 of 584) with videos related to
Page
of 59
Sort By:
Nature Medicine
|
May 15, 2024
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
Xiaohua Wu, Jihong Liu, Jing Wang, et al.
JAMA Oncology
|
July 13, 2023
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical Trial
Ning Li, Jianqing Zhu, Rutie Yin, et al.
Nature Communications
|
June 11, 2026
TaMPK3 mediates synergistic damage from Fusarium crown rot and drought in wheat
Lei Zheng, Tai-Fei Yu, Ying Liu, et al.
Eclinicalmedicine
|
May 15, 2024
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial
Xiaohua Wu, Jianqing Zhu, Rutie Yin, et al.
JCI Insight
|
May 22, 2024
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
Yi-Hsuan Chang, Min-Feng Hsu, Wei-Nan Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2022
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Ning Li, Youzhong Zhang, Jing Wang, et al.
Chinese Medical Journal
|
November 15, 2017
Proportion of Uterine Malignant Tumors in Patients with Laparoscopic Myomectomy: A National Multicenter Study in China
Hua Yang, Xiao-Chuan Li, Chen Yao, et al.
Plos Genetics
|
November 21, 2012
Genome, functional gene annotation, and nuclear transformation of the heterokont oleaginous alga Nannochloropsis oceanica CCMP1779
Astrid Vieler, Guangxi Wu, Chia-Hong Tsai, et al.
Plos Genetics
|
May 26, 2017
Correction: Genome, Functional Gene Annotation, and Nuclear Transformation of the Heterokont Oleaginous Alga Nannochloropsis oceanica CCMP1779
Astrid Vieler, Guangxi Wu, Chia-Hong Tsai, et al.
CA: a Cancer Journal for Clinicians
|
November 25, 2025
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Lingying Wu, Jing Wang, Qingshui Li, et al.
Page
of 59
Search research articles
Search
Showing results (571-580 of 584) with videos related to
Sort By:
Page
of 59
Nature Medicine
|
May 15, 2024
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
Xiaohua Wu, Jihong Liu, Jing Wang, et al.
JAMA Oncology
|
July 13, 2023
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical Trial
Ning Li, Jianqing Zhu, Rutie Yin, et al.
Nature Communications
|
June 11, 2026
TaMPK3 mediates synergistic damage from Fusarium crown rot and drought in wheat
Lei Zheng, Tai-Fei Yu, Ying Liu, et al.
Eclinicalmedicine
|
May 15, 2024
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial
Xiaohua Wu, Jianqing Zhu, Rutie Yin, et al.
JCI Insight
|
May 22, 2024
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
Yi-Hsuan Chang, Min-Feng Hsu, Wei-Nan Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2022
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Ning Li, Youzhong Zhang, Jing Wang, et al.
Chinese Medical Journal
|
November 15, 2017
Proportion of Uterine Malignant Tumors in Patients with Laparoscopic Myomectomy: A National Multicenter Study in China
Hua Yang, Xiao-Chuan Li, Chen Yao, et al.
Plos Genetics
|
November 21, 2012
Genome, functional gene annotation, and nuclear transformation of the heterokont oleaginous alga Nannochloropsis oceanica CCMP1779
Astrid Vieler, Guangxi Wu, Chia-Hong Tsai, et al.
Plos Genetics
|
May 26, 2017
Correction: Genome, Functional Gene Annotation, and Nuclear Transformation of the Heterokont Oleaginous Alga Nannochloropsis oceanica CCMP1779
Astrid Vieler, Guangxi Wu, Chia-Hong Tsai, et al.
CA: a Cancer Journal for Clinicians
|
November 25, 2025
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Lingying Wu, Jing Wang, Qingshui Li, et al.
Page
of 59